Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets. It generates revenue from three segments: Life Sciences and Applied Markets (~40%), Diagnostics and Genomics (~35%), and Agilent CrossLab (~25%). The company offers chromatography systems, mass spectrometry instruments, DNA analysis tools, and lab services. Its growth is supported by ongoing innovation and a diverse product portfolio, but faces competition and dependence on research funding in the life sciences sector.
—
Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets. It generates revenue from three segments: Life Sciences and Applied Markets (~40%), Diagnostics and Genomics (~35%), and Agilent CrossLab (~25%). The company offers chromatography systems, mass spectrometry instruments, DNA analysis tools, and lab services. Its growth is supported by ongoing innovation and a diverse product portfolio, but faces competition and dependence on research funding in the life sciences sector.
—
Daily adjusted close
Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets. It generates revenue from three segments: Life Sciences and Applied Markets (~40%), Diagnostics and Genomics (~35%), and Agilent CrossLab (~25%). The company offers chromatography systems, mass spectrometry instruments, DNA analysis tools, and lab services. Its growth is supported by ongoing innovation and a diverse product portfolio, but faces competition and dependence on research funding in the life sciences sector.